Mar. 30 at 5:14 AM
$CRSP I’ve known about CRISPR forever but it isn’t until now I’ve been contemplating starting a position at these more favorable prices.
Casgevy is maturing and finding its stride in the market, revenue is climbing, ATCs becoming more established, TONS of catalysts this year.
2026 will be a telling year as to the direction Casgevy is heading.
Interesting to raise
$550 million when you already have near
$2 billion cash on hand. How much is enough? Is there more at play than simply raising this capital for “general corporate purposes”? Possibly.
